RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $453,000 | +35.6% | 158,800 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $334,000 | -73.6% | 158,989 | -42.9% | 0.00% | -66.7% |
| Q2 2020 | $1,267,000 | -62.7% | 278,404 | -33.1% | 0.00% | -70.0% |
| Q1 2020 | $3,401,000 | -56.3% | 416,261 | -2.0% | 0.01% | -41.2% |
| Q4 2019 | $7,788,000 | +1204.5% | 424,859 | +688.1% | 0.02% | +1600.0% |
| Q3 2019 | $597,000 | +4875.0% | 53,908 | +4484.0% | 0.00% | – |
| Q2 2019 | $12,000 | +140.0% | 1,176 | +139.0% | 0.00% | – |
| Q1 2018 | $5,000 | +400.0% | 492 | +351.4% | 0.00% | – |
| Q3 2015 | $1,000 | -90.0% | 109 | -86.5% | 0.00% | – |
| Q2 2015 | $10,000 | – | 808 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |